Antibiotic Discovery: Where Have We Come from, Where Do We Go?

Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly approved antibiotics for clinical usage, we are on the verge of not having effective treatments for many common infectious diseases. Historically, antibiotic discovery has been crucial in outpacing resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro da Cunha, Bernardo, Fonseca, Luís P., Calado, Cecília R. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627412/
https://www.ncbi.nlm.nih.gov/pubmed/31022923
http://dx.doi.org/10.3390/antibiotics8020045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627412/
https://www.ncbi.nlm.nih.gov/pubmed/31022923
http://dx.doi.org/10.3390/antibiotics8020045

Ejemplares similares